Clinical Trials Logo
  1. Home
  2. Stents
  3. NCT01056744

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents — OCTOPUS  

Stents Clinical Trial

Official title:
Endothelial Stent Coverage and Neointimal Proliferation at 6 Months After Implantation of a Coronary Everolimus-Eluting Stent Compared With a Bare Metal Stent Postdilated With a Paclitaxel-Eluting Balloon: A Randomised Study Using Optical Coherence Tomography

Clinical Trial Summary

Background:

Safety concerns regarding use of drug eluting stent systems (DES) are related mostly to late stent thrombosis, which is facilitated by incomplete stent endothelial coverage. Specific information about time course and amount of endothelial strut coverage of different DES is required, in order to further refine the concept of antiplatelet therapy after DES implantation. Optical coherence tomography (OCT) is emerging as a new gold standard for endovascular imaging of stents, atherosclerosis progression, vulnerable plaque and neointimal proliferation. Very limited OCT data about endothelial coverage of DES are currently available. Aim of this study is a comparative evaluation of XIENCE V® everolimus eluting stent (Abbot Vascular) and of the bare metal stent (BMS) Coroflex® Blue postdilated with the drug-eluting balloon (DEB) SeQuent® Please (paclitaxel-eluting balloon, B. Braun Melsungen AG) in terms of endothelial coverage and neointimal proliferation using OCT.

Study Design:

A number of 80 patients scheduled for elective percutaneous coronary intervention (PCI) with a native coronary stenosis suitable for DES implantation and OCT imaging are openly randomized 1:1 to either XIENCE V® or Coroflex® Blue/Sequent® Please. The study is prospectively conducted at a university high-volume PCI center with OCT expertise (Jena, Germany). Angiographic follow-up and OCT imaging with motorized pull-back at 1 mm/s are planned in all patients 6 months after implantation of the study stents. OCT endpoints are: (1) endothelial coverage, expressed as % of struts without coverage and % of stent length containing non-covered struts, and respectively (2) neointimal proliferation, given as % neointimal volumetric proliferation within the whole stent and also as focal peak % neointimal area proliferation. The study is not powered for clinical endpoints, which are: subacute or late stent thrombosis and need for revascularization of the stent segment. Given the high number of measurements (15 cross-section images / 1 mm stent length), OCT endpoints are likely to reach significance at the level P < 0.05 even at a follow-up drop-out rate up to 20%.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01056744
Study type Interventional
Source University of Jena
Contact
Status Completed
Phase Phase 4
Start date June 2009
Completion date June 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT01900691 - Removal of the Evolution® Esophageal Stent - Fully Covered N/A
Recruiting NCT05872074 - Immediate and Short Term Outcomes for Using Drug Coated Balloons in Treating Coronary Bifurcation Lesions N/A
Enrolling by invitation NCT01172158 - SMS Reminder for Forgotten Ureteral Stents N/A
Completed NCT04115696 - Biodegradable Stent Implantation in Biliary Benign Strictures.
Completed NCT01124942 - MGuard Stent in ST-elevation Myocardial Infarction N/A
Completed NCT02811796 - Angio-based Fractional Flow Reserve to Predict Adverse Events After Stent Implantation
Recruiting NCT01997242 - The Surgery After Stenting (SAS) Registry N/A
Completed NCT00691314 - Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis N/A
Completed NCT00180479 - SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) Phase 3
Completed NCT03521700 - Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement Phase 2/Phase 3
Active, not recruiting NCT01160900 - FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. Phase 3
Completed NCT00937573 - Xience V at Wake Forest University Baptist Medical Center (WFUBMC) N/A
Recruiting NCT00637104 - European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent Phase 2/Phase 3
Completed NCT03989557 - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms Phase 4
Withdrawn NCT03375411 - First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions. N/A
Completed NCT01962168 - Evolution® Biliary Stent System Clinical Study N/A
Completed NCT00769938 - WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) Phase 4
Completed NCT05556668 - Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.
Terminated NCT03119012 - P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold Phase 4